About Radiolife
Radiolife is a Healthcare company based in Wilmington (United States) founded in 2021 by Sergio Schirmer. AI and radio-frequency signatures are used for diagnostics and therapeutics. Its chief executive, as recorded, is Sergio Schirmer. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include Genalyte, Enumera Molecular and Muzi; 2 of its 3 listed competitors have raised funding.
Company details
Radiolife was founded in 2021 in Wilmington, United States, and operates in the health technology sector. AI-powered digital solutions for diagnostics and therapeutics are developed. A portable device known as Cube Scan is produced for in-vitro analysis. Radio-frequency signatures combined with artificial intelligence modeling are employed to detect viruses, bacteria, and cancer cells.
Apps and channels of Radiolife
its YouTube channel Radiolife has 131 subscribers and 3 videos.
Videos from Radiolife
The most watched videos on Radiolife's YouTube channel, Radiolife (131 subscribers). Click a video to play it here.
More on Radiolife.
People of Radiolife
2 people are tracked at Radiolife (2 in leadership).
| Name | Role | Group |
|---|---|---|
Sergio Schirmer | Founder & CEO | Leadership |
Sergio Ribeiro | CEO | Leadership |
Complete people profiles for Radiolife
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Radiolife
Radiolife has 3 listed competitors in our database, 2 of them funded. They include Genalyte, Enumera Molecular and Muzi.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genalyte.com | 2007 | San Diego, United States | $141.8M | 113 | Silicon photonics-based multiplexing tools for biomolecular detection are developed. | |
| enumeramolecular.com | 2022 | Ann Arbor, United States | $18.72M | Liquid biopsy tools are developed for biomolecule assessment. | ||
| muzitech.com | 2016 | San Francisco, United States | RDTs are interpreted using smartphones and AI on Muzi's platform. |
Detailed competitors of Radiolife
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Radiolife (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Radiolife
Radiolife was founded in 2021.
Radiolife is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
Sergio Schirmer is the CEO of Radiolife, as recorded in our data. They have also founded this company.
Radiolife was founded in 2021 in Wilmington, United States, and operates in the health technology sector. AI-powered digital solutions for diagnostics and therapeutics are developed. A portable device known as Cube Scan is produced for in-vitro analysis. Radio-frequency signatures combined with artificial intelligence modeling are employed to detect viruses, bacteria, and cancer cells.
Radiolife's top competitors include Genalyte, Enumera Molecular and Muzi.